NCT07153471: A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
- State
- Under way
- Phase
- Phase 3
- People
- 800 planned
- Started
- 15 Sep 2025
- Primary completion
- Apr 2028
- Arms
- Orforglipron (GZT1), Orforglipron (GZT2)
- Results
- None posted
- 4 Sep 2025: Trial registered
- 15 Sep 2025: Trial started